U-51754 is a synthetic research chemical known to belong to the arylcyclohexylamine and piperidine class of compounds. It is believed to act primarily as a kappa-opioid receptor agonist, with a structure similar to U-50488 and U-69593. U-51754 has no documented use in humans and is strictly for analytical, pharmacological, and receptor binding research under controlled laboratory conditions.

• Chemical Classification
  U-51754 is categorized as an arylcyclohexylamine with structural ties to both dissociatives and opioid receptor modulators. It contains a phenylcyclohexyl core fused with a piperidine ring, positioning it uniquely among both stimulatory and dissociative analogues.

• Pharmacological Target
  The compound selectively binds to the kappa-opioid receptor (KOR), making it valuable in studies involving pain perception, opioid modulation, and mood-related mechanisms.

• Research Applications
  U-51754 is used in in vitro and in vivo animal research to investigate the pharmacokinetics and pharmacodynamics of kappa-opioid selective ligands. It can help model non-addictive pain therapies.

• Comparison with Known Analogs
  Compared to more established kappa agonists like U-50488, U-51754 is less documented but is structurally similar, allowing researchers to explore potential differences in receptor binding profiles and efficacy.

• Status in Human Research
  There is no existing peer-reviewed literature indicating human trials or anecdotal recreational use. Its safety profile in humans is unverified and highly discouraged for personal use.

• Legal Status
  U-51754 is not a controlled substance in most jurisdictions as of now. However, its similarity to regulated compounds means local analog laws could apply.

U-51754 is unscheduled at the international level and in most countries, but that doesn’t automatically guarantee legal clearance for possession or importation. Its legality often depends on the structure-analogue provisions or blanket laws present in individual regions.

• Not Scheduled by Major International Bodies
  The compound is currently not listed under the United Nations Convention on Psychotropic Substances or by most national drug enforcement agencies.

• Controlled Under Analog Laws in Some Regions
  Certain countries (e.g., the USA, UK, Germany, Australia) may classify U-51754 as an analog of scheduled substances, even if it isn’t specifically named.

• Customs and Border Confiscation Risk
  Due to its classification as a research chemical, it may raise red flags with customs authorities, especially when shipped internationally. Discreet packaging from RC Plug reduces this risk significantly.

• Research Use Legally Safer
  Laboratories and institutions conducting licensed or university-approved studies are more likely to operate within legal bounds when acquiring and storing U-51754.

• RC Plug’ Compliance Statement
  All sales of U-51754 are under the condition that it is used for scientific research only. Buyers are fully responsible for ensuring it is legal to import and possess in their country or region.

• No Liability for Local Regulations
  While we provide discreet shipping and stealth labeling, RC Plug assumes no responsibility for seizure or legal action due to regional legal non-compliance.

U-51754 is typically sold and distributed as a white to off-white crystalline powder. Its appearance can vary slightly depending on synthesis conditions and storage, but certain characteristics remain consistent.

• Color and Form
  U-51754 is usually a fine, white to slightly off-white powder with a crystalline structure. Minimal color deviation does not imply impurity if verified by lab results.

• Texture and Consistency
  The compound may feel dry and flaky or slightly granular depending on moisture retention during processing. It is not sticky or oily under proper storage conditions.

• Purity Indications
  While physical appearance is not a definitive purity measure, consistent crystallization and lack of discoloration often signal proper synthesis and minimal byproduct contamination.

• Packaging Appearance
  RC Plug ships U-51754 in sealed, laboratory-safe pouches labeled for research use only. No branding or product name is printed on external packaging to maintain anonymity.

• Storage Effects
  Poor storage (exposure to humidity, light, or air) may cause clumping, discoloration, or degradation. The compound should always be kept in a dry, cool, dark environment.

U-51754 has gained attention for its potential as a selective kappa-opioid receptor agonist. In controlled studies, it is used to evaluate neurological, analgesic, and receptor-specific activity without triggering mu-opioid receptor pathways, which are often associated with addictive effects.

• Receptor Binding Affinity
  U-51754 binds to the kappa-opioid receptor (KOR) with moderate to high affinity, potentially influencing stress responses, pain perception, and mood without the reward-driven patterns of mu-opioid agonists.

• Behavioral Pharmacology
  In animal models, kappa agonists like U-51754 are studied for sedative, anxiolytic, and antinociceptive effects, though results for this specific compound remain unpublished.

• Opioid Pathway Research
  Its selectivity makes it a powerful tool for distinguishing kappa-receptor effects from mu- and delta-related mechanisms, aiding in the development of next-generation non-addictive pain treatments.

• Antidepressant and Dysphoric Modeling
  Kappa agonists often produce dysphoria in humans, but this effect is under investigation for potential therapeutic redirection in models of treatment-resistant depression or PTSD.

• SAR Studies
  U-51754 can also be used in Structure-Activity Relationship (SAR) studies to analyze how structural modifications affect receptor targeting and metabolic stability.

There is no confirmed human research or anecdotal documentation suggesting U-51754 has psychoactive effects. Although it acts on a receptor system known to influence perception and mood, its behavioral or experiential effects remain speculative and unverified.

• Kappa Receptor Effects Are Non-Euphoric
  Compounds that target the kappa-opioid receptor are known for producing dysphoric rather than euphoric effects in animal and human models.

• No Published Human Experience Reports
  Unlike some dissociative analogs, U-51754 has not been mentioned in case reports or recreational drug forums, indicating it lacks known psychoactive or recreational potential.

• Designed for Research, Not Experience
  The compound is intended solely for chemical and pharmacological investigation, not for consumption, inhalation, or injection.

• Limited Central Nervous System Data
  Without in vivo data on CNS penetration, it’s impossible to speculate with accuracy about possible psychological or perceptual changes in humans.

• Possibility of Unwanted Effects
  If misused, kappa agonists can induce side effects such as anxiety, hallucinations, or motor suppression—not desirable or safe for non-laboratory settings.

Proper storage of U-51754 is essential to preserve its chemical stability, prevent degradation, and maintain its research-grade purity. As a synthetic compound with hygroscopic properties, it must be kept in conditions that avoid exposure to moisture, heat, and light.

• Ideal Storage Temperature
  U-51754 should be stored at -20°C or lower to ensure maximum shelf life. Low temperatures slow down any potential decomposition or molecular rearrangement.

• Moisture Protection
  The compound is hygroscopic, meaning it absorbs moisture from the air. It should be stored in airtight, moisture-resistant containers, preferably with desiccants to control humidity.

• Avoid Light Exposure
  UV and fluorescent light can degrade chemical bonds over time. Store U-51754 in opaque or amber-colored vials, inside a dark storage cabinet or freezer.

• Air Exposure
  Frequent exposure to oxygen may cause oxidation or other chemical changes. Always reseal containers tightly after each use and consider inert gas flushing (e.g., nitrogen) for long-term storage.

• Vacuum-Sealing for Long-Term Use
  For multi-month preservation, vacuum-sealed storage in laminated foil pouches or glass ampoules is recommended. This prevents both air and moisture intrusion.

• Labeling and Handling
  Clearly label the container with the compound name, date of receipt, and batch number. Use gloves and lab attire during handling to avoid contamination.

• Safety Storage Protocol
  Keep U-51754 away from all food, consumables, and unauthorized personnel. Lockable, ventilated chemical cabinets are ideal for institutions and labs.

While U-51754 is designated for laboratory use only, it still presents potential hazards if not handled according to proper safety protocols. Its pharmacological effects are not fully understood, and like many research chemicals, it may pose both chemical and biological risks.

• Unknown Toxicological Profile
  The long-term or acute toxicity of U-51754 in humans is not documented, making accidental exposure a serious concern. Always handle under fume hoods with protective gear.

• Skin and Mucosal Irritation
  Contact with the skin or eyes may cause irritation or allergic responses. Use nitrile gloves, safety goggles, and lab coats during all handling procedures.

• Inhalation Risks
  As a fine powder, U-51754 can become airborne if mishandled. Avoid inhalation by using a certified fume hood and wearing a NIOSH-approved particulate respirator if aerosolization is possible.

• Accidental Ingestion Danger
  Accidental oral ingestion—even in microgram quantities—may result in unpredictable biological effects. Do not eat or drink near workspaces where U-51754 is handled.

• Environmental Contamination
  Spills should be cleaned with absorbent materials and neutralizing agents, and disposed of as hazardous waste in accordance with your institution’s safety guidelines.

• Not for Human or Veterinary Use
  U-51754 must never be used in clinical, recreational, or veterinary settings. Its sole purpose is for qualified scientific research.

• Emergency Protocols
  Laboratories must maintain MSDS documentation, eyewash stations, and first aid kits where U-51754 is stored or used.

Based on the receptor pathways it targets, U-51754 is unlikely to have high addictive potential, but conclusive data is lacking due to the absence of human or extensive in vivo testing. Its classification as a kappa-opioid receptor agonist suggests it may even have anti-rewarding or aversive effects in behavioral models.

• Acts on Kappa-Opioid Receptors
  Unlike mu-opioid agonists such as morphine or fentanyl, U-51754 is thought to avoid the euphoria-inducing pathways, making it less likely to reinforce compulsive use behavior.

• Low Dopamine Activation
  Kappa agonists generally suppress dopamine release, which is the opposite of what occurs in most addictive drugs. This suggests a low addiction profile pharmacologically.

• Preclinical Observations
  Structural analogs like U-50488 and U-69593 have demonstrated non-rewarding profiles in animal studies, which may extend to U-51754, although direct data is still needed.

• Absence of Recreational Reports
  No credible online reports or case studies indicate any recreational misuse of U-51754, reinforcing its apparent lack of abuse potential.

• May Cause Dysphoria
  Kappa receptor stimulation is often associated with dysphoric, sedative, or aversive sensations, further reducing its appeal as an addictive substance.

• Still Requires Handling with Caution
  Despite the low expected abuse risk, all research chemicals should be handled with care and never self-administered under any circumstances.

U-51754 is considered chemically stable under ideal storage conditions and can remain viable for over a year, provided it is kept at a consistent low temperature and protected from moisture and light. Proper storage practices dramatically influence the shelf life and integrity of the compound.

• Stability Duration
  Under laboratory-standard storage conditions (-20°C, airtight, dry), U-51754 maintains chemical stability for 12 to 18 months without significant degradation.

• Degradation Factors
  Factors such as heat, UV light, oxygen, and humidity accelerate degradation, leading to possible structural breakdown and reduced efficacy in experiments.

• Batch-Specific Testing
  RC Plug verifies stability through periodic lab testing using spectrometry or chromatography, ensuring each batch retains its molecular profile over time.

• Visual Indicators of Instability
  Discoloration, moisture clumping, or changes in texture may indicate chemical alteration. These changes should prompt researchers to discard or retest the compound.

• Use of Desiccants
  Silica gel or molecular sieve packs included in storage containers can further extend stability by maintaining a dry environment.

• Refrigeration vs. Freezing
  While refrigeration (4°C) is acceptable for short-term storage, freezer conditions (-20°C) are highly recommended for long-term preservation.

U-51754 is not included in routine drug screening panels used by employers, probation offices, or most forensic labs. However, it can be detected using specialized testing equipment in academic or advanced toxicology settings.

• Not Targeted in Common Panels
  Standard immunoassay-based drug tests (e.g., for opiates, benzodiazepines, THC) do not detect U-51754, as it falls outside their testing spectrum.

• Requires Advanced Analytical Methods
  Detection typically involves GC-MS (Gas Chromatography-Mass Spectrometry) or LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry), which are used in forensic and research labs.

• No Commercial Test Kits Available
  As of now, there are no commercially available rapid test kits that include U-51754, making detection rare outside of specialized settings.

• Possible Cross-Reactivity with Analogues
  In rare cases, analog-based laws or customized panels may flag compounds that are structurally similar to known opioids or dissociatives.

• Forensic Analysis Capable of Identification
  Toxicology laboratories with a focus on novel psychoactive substances (NPS) can identify U-51754 through custom compound libraries and spectral matching.

• Not Intended for Consumption
  Since U-51754 is not for human use, testing for it typically applies to law enforcement, research validation, or contamination checks—not personal drug testing.

U-51754 shares core structural elements with both dissociative and opioid analogues, primarily due to its arylcyclohexylamine backbone and the incorporation of a piperidine ring. This unique arrangement makes it an interesting compound for receptor-specific studies and structure–activity relationship (SAR) modeling.

• Core Framework: Arylcyclohexylamine
  The structure centers around a phenylcyclohexyl group, a feature common to well-known dissociatives such as PCP and ketamine. This core contributes to its pharmacokinetic behavior and hydrophobic properties.

• Presence of a Piperidine Ring
  A piperidine moiety is connected to the cyclohexyl unit, influencing its interaction with opioid receptors. Piperidine rings are also found in pharmaceutical opioids like fentanyl, although U-51754 lacks direct mu-opioid activity.

• Similarity to U-Series Compounds
  It is structurally comparable to U-50488 and U-69593, two compounds known for their high selectivity for the kappa-opioid receptor. These similarities guide researchers in comparative efficacy and receptor affinity studies.

• Non-Stereoselective
  U-51754 may exist in multiple stereoisomeric forms, though current availability is primarily in racemic (non-chiral) form. This could influence binding potency in future studies.

• Molecular Configuration
  The compound’s molecular formula is C17H27NO, with a molecular weight of approximately 261.4 g/mol. It has a moderately lipophilic profile, making it suitable for CNS receptor mapping.

• Absence of Functional Groups Common in Other Opioids
  Unlike classical opioids, U-51754 does not include a hydroxyl group or ether bridge, which reduces its affinity for mu-receptors but increases its kappa selectivity.

U-51754’s selective receptor activity and unique structure make it suitable for a variety of preclinical, neuropharmacological, and receptor profiling studies. It allows researchers to investigate kappa-opioid pathways without cross-activating mu-opioid responses, which are linked to addiction and sedation.

• Receptor Binding Studies
  U-51754 is often used in assays designed to map receptor selectivity, especially the affinity and potency at the kappa-opioid receptor (KOR). These studies help differentiate between receptor subtypes and analyze antagonist interactions.

• Structure–Activity Relationship (SAR) Modeling
  The compound serves as a benchmark or variable in SAR studies, aiding in the development of more refined opioid receptor modulators for pain, anxiety, and depression treatment pathways.

• Neurological Impact Testing
  In controlled environments, U-51754 may be used to model central nervous system (CNS) responses such as sedation, stress reactivity, or dysphoria without traditional euphoria, helping isolate the behavioral effects of kappa-agonism.

• Analogue Comparison Studies
  Researchers compare U-51754 to known compounds like U-50488 or ketamine to evaluate differences in onset, duration, solubility, and receptor binding strength, leading to the synthesis of better therapeutic leads.

• Analgesic and Antidepressant Model Exploration
  While not clinically approved, U-51754 is examined for non-euphoric pain modulation and resilience-based mood studies—fields seeking kappa-based therapeutic interventions.

U-51754 may be used in non-human animal models for experimental purposes, particularly when studying opioid receptor pharmacology, behavioral neuroscience, and neurochemical pathways. However, such use must follow ethical protocols and institutional oversight.

• Rodent-Based Pharmacological Testing
  Researchers use U-51754 in rodent trials to assess behavioral changes, receptor selectivity, and response thresholds to kappa-opioid stimulation.

• Pain Modulation Models
  It can serve in analgesia testing paradigms, measuring reaction times, nociception, or stress-induced pain behavior when kappa-agonist activity is desired.

• Depression and Dysphoria Models
  Animal studies involving learned helplessness or forced swim tests may include U-51754 to observe kappa-opioid impact on affective behaviors and resilience mechanisms.

• Locomotor and Coordination Assessments
  Behavioral studies track changes in motor coordination or exploratory behavior after dosing with kappa agonists like U-51754.

• Toxicology and Safety Profiling
  Prior to any potential human application (which is not approved), toxicology profiling in animals may help identify safe exposure limits and adverse effect thresholds.

• Regulatory Compliance Required
  Any research involving animals must be approved by an Institutional Animal Care and Use Committee (IACUC) or its equivalent to comply with ethical standards.

Due to its moderate solubility characteristics, U-51754 is most effectively dissolved in organic solvents, particularly those commonly used in lab preparation for chemical analysis or receptor binding assays.

• Ethanol
  U-51754 dissolves well in absolute or high-purity ethanol, making it suitable for use in radioligand assays and solvent-based delivery mechanisms.

• Dimethyl Sulfoxide (DMSO)
  DMSO offers high solubilizing power for U-51754 and is often used in cell-based assays or when high concentration stock solutions are required.

• Propylene Glycol (PG)
  For controlled-release formulations or dose simulations, PG is sometimes used as a mild solvent due to its compatibility and viscosity control.

• Acetonitrile
  This is another option for HPLC or analytical preparation, offering good miscibility and evaporative properties.

• Water Solubility is Poor
  U-51754 has low water solubility, which limits its direct use in aqueous environments without co-solvents or surfactants.

• Storage of Solutions
  Solvent-dissolved U-51754 should be stored in sealed, light-protected vials at cold temperatures, preferably under -20°C, to avoid degradation.

Although U-51754 belongs to the arylcyclohexylamine class—structurally associated with dissociatives like ketamine and PCP—it does not function primarily as a dissociative. Instead, it is believed to act as a kappa-opioid receptor agonist, producing distinct neuropharmacological effects that are separate from classic NMDA antagonism.

• Primary Mechanism is Opioid, Not NMDA
  Unlike ketamine or MXE, U-51754 does not appear to antagonize NMDA receptors. Its main action is through KOR activation, which alters mood, pain perception, and stress responsiveness.

• Minimal Psychoactive Reports
  There are no known subjective experience reports of U-51754 inducing dissociative effects such as detachment, time dilation, or sensory disconnection, which are hallmarks of NMDA antagonists.

• No Known Hallucinogenic Activity
  Kappa agonists can cause dysphoria or hallucination-like phenomena in high doses, but these effects differ mechanistically and experientially from classical dissociatives.

• Structurally Similar but Functionally Divergent
  While the molecular backbone overlaps with arylcyclohexylamine dissociatives, U-51754’s piperidine substitution alters its receptor profile, diverting activity away from glutamatergic systems.

• Used for Receptor Studies, Not Mind-State Modeling
  Its role in research is focused on selective opioid receptor investigation, not the study of consciousness, hallucination, or anesthesia.

Yes, at RC Plug, we offer a 30-day return and replacement policy for all eligible purchases, including U-51754. We stand behind the quality of our research chemicals and prioritize your satisfaction as a customer. Returns are accepted under specific conditions to ensure safety, product integrity, and transparency.

• 30-Day Return Window
  You may return U-51754 within 30 days of receiving the package, provided it remains in its original, unopened condition.

• Eligible Return Reasons
  Returns are typically accepted in cases of shipping errors, damaged goods, incorrect product delivery, or compromised packaging. Returns due to regulatory seizure or misuse do not qualify.

• Product Integrity Must Be Intact
  The chemical must be in its original packaging, unopened, and properly stored to be eligible for a full refund or exchange.

• Replacement Option Available
  If the return is due to damage or defect, you may choose a replacement shipment at no additional charge, pending review by our support team.

• Fast Customer Service Response
  Our support team usually responds to return inquiries within 24–48 hours, ensuring quick resolution.

• Refund Processing
  Refunds are issued using the original payment method, including Bitcoin, bank transfer, Zelle, or CashApp. Processing time may vary depending on the platform used.

• Contact Support to Begin the Return
  To initiate a return, reach out to our customer support with your order ID, issue description, and photo evidence (if applicable).